健友股份(603707.SH)子公司获得美国FDA注射用维库溴铵药品增加生产场地注册批件

Core Viewpoint - Meitheal Pharmaceuticals, Inc., a subsidiary of Jianyou Co., has received approval from the U.S. FDA to increase production facilities for injectable Vecuronium Bromide, 10mg/vial and 20mg/vial, at its Nanjing facility [1] Group 1 - The approval pertains to ANDA number 074688, allowing for expanded production capabilities [1]